Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-26 @ 3:16 PM
NCT ID: NCT07426003
Eligibility Criteria: Inclusion Criteria: 1. Must be able to read and understand English 2. Must be able to sign a consent form for the study Exclusion Criteria: 1. BMI \<20 or \>30 2. Unintentional weight loss of \>10% in the last 3-6 months 3. Kidney disease 4. Diagnosis of cirrhosis 5. Taking diuretics 6. Anemia - Hemoglobin \<lower limit of normal in men or \<10 g/dL in women. 7. Taking iron supplements within 2 weeks for Visit 2.1 8. Taking prebiotic or probiotic supplements or any supplement including a multivitamin within 2 weeks of Visit 2.1 9. Taking antibiotics less than 4 weeks prior to Visit 2.1 10. Diarrhea in the 2 weeks prior to Visit 2.1 11. Diabetes mellitus 12. Diagnosis of congestive heart failure 13. Diagnosis of inflammatory bowel disease or celiac disease 14. Bowel resection other than an appendectomy 15. Pregnancy or breastfeeding 16. Intolerance or allergy to nutritional formula, chicken, eggs, apples, banana, potatoes 17. Using protein supplements, including powder added to food or drinks within 2 weeks of Visit 2.1 18. Baseline bowel frequency less than every 2 days or greater than 3 times daily 19. Student or employee of any one of the investigators. 20. Anyone who cannot receive study payment (e.g. visa constraints). 21. Any condition that the investigator feels may limit the volunteer's ability to complete the study protocol.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT07426003
Study Brief:
Protocol Section: NCT07426003